Recent Advancement in Novel Wound Healing Therapies by Using Antimicrobial Peptides Derived from Humans and Amphibians
- Authors: Satapathy T.1, Kishore Y.1, Pandey R.1, Shukla S.S.1, Bhardwaj S.K.1, Gidwani B.1
-
Affiliations:
- Department of Pharmacology, Columbia Institute of Pharmacy
- Issue: Vol 25, No 8 (2024)
- Pages: 587-603
- Section: Life Sciences
- URL: https://archivog.com/1389-2037/article/view/645696
- DOI: https://doi.org/10.2174/0113892037288051240319052435
- ID: 645696
Cite item
Full Text
Abstract
The skin is the biggest organ in the human body. It is the first line of protection against invading pathogens and the starting point for the immune system. The focus of this review is on the use of amphibian-derived peptides and antimicrobial peptides (AMPs) in the treatment of wound healing. When skin is injured, a chain reaction begins that includes inflammation, the formation of new tissue, and remodelling of existing tissue to aid in the healing process. Collaborating with non-immune cells, resident and recruited immune cells in the skin remove foreign invaders and debris, then direct the repair and regeneration of injured host tissues. Restoration of normal structure and function requires the healing of damaged tissues. However, a major issue that slows wound healing is infection. AMPs are just one type of host-defense chemicals that have developed in multicellular animals to regulate the immune response and limit microbial proliferation in response to various types of biological or physical stress. Therefore, peptides isolated from amphibians represent novel therapeutic tools and approaches for regenerating damaged skin. Peptides that speed up the healing process could be used as therapeutic lead molecules in future research into novel drugs. AMPs and amphibian-derived peptides may be endogenous mediators of wound healing and treat non-life-threatening skin and epithelial lesions. Hence, this article describes different peptides used in wound healing, theirmethods of preparation, and their routes of administration.
Keywords
About the authors
Trilochan Satapathy
Department of Pharmacology, Columbia Institute of Pharmacy
Author for correspondence.
Email: info@benthamscience.net
Yugal Kishore
Department of Pharmacology, Columbia Institute of Pharmacy
Email: info@benthamscience.net
Ravindra Pandey
Department of Pharmacology, Columbia Institute of Pharmacy
Email: info@benthamscience.net
Shiv Shankar Shukla
Department of Pharmacology, Columbia Institute of Pharmacy
Email: info@benthamscience.net
Shiv Kumar Bhardwaj
Department of Pharmacology, Columbia Institute of Pharmacy
Email: info@benthamscience.net
Beena Gidwani
Department of Pharmacology, Columbia Institute of Pharmacy
Email: info@benthamscience.net
Supplementary files
